LoginPfizer to Acquire Obesity Drug Start-Up Metsera in $10 Billion Deal
The announcement of the deal signaled an end to the bidding war for Metsera between Pfizer and Novo Nordisk, the Danish maker of Ozempic and Wegovy.
Pfizer’s deal to acquire Metsera came after a bidding war with the Danish company Novo Nordisk.
© Mike Blake/Reuters
